Alan Oglesby, MPH

Sr. Director
ViiV Healthcare

Disclosure(s): GSK: Stocks/Bonds (Public Company); ViiV Healthcare: Employee

Alan Oglesby, MPH, is a Senior Director of Health Outcomes Research at ViiV Healthcare. He has over 20 years of experience in health economics and outcomes research and has authored over 40 peer review manuscripts and 90 abstracts across a variety of therapeutic areas including HIV, oncology, lupus, diabetes, and women's health issues.

Poster(s):

• (P-500) Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1415) Social Determinants of Health and Side Effects Significantly Predict Pre-Exposure Prophylaxis (PrEP) Preferences for Every 2 Month Long-Acting Injectable vs. Daily Oral PrEP among Cisgender Women in the United States and the Dominican Republic
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT